Optimal cancer evasion in a dynamic immune microenvironment generates diverse post-escape tumor antigenicity profiles

Jason T George1,2,3, Herbert Levine3,4,5

  • 1Department of Biomedical Engineering, Texas A&M University, Houston, United States.

Elife
|April 25, 2023
PubMed

Insights

Cancer treatments often fail due to tumor evolution. This study introduces a mathematical model for adaptive immune evasion, showing optimal strategies increase evasion rates and lead to diverse tumor antigenicity.

Area of Science:

  • Oncology
  • Immunology
  • Mathematical Biology

Background:

  • Cancer treatment failure, particularly with immunotherapy, is a significant clinical challenge.
  • Tumor evolution, encompassing genotypic and phenotypic changes, drives resistance to therapies.
  • Understanding tumor adaptation and immune evasion is crucial for developing effective cancer treatments.

Purpose of the Study:

  • To develop a mathematical framework for analyzing adaptive immune evasion dynamics in cancer.
  • To identify the optimal cancer evasion strategy using computational methods.
  • To investigate the relationship between immune microenvironment features and cancer evasion.

Main Methods:

  • Utilized stochastic dynamic programming to solve for the optimal cancer evasion strategy.
  • Developed a mathematical model tracking tumor-associated antigens available for immune targeting.
  • Analyzed the dynamics of adaptive immune evasion in varying selective environments.

Main Results:

  • The optimal adaptive cancer evasion strategy significantly increases evasion rates compared to passive strategies.
  • Tumor immunogenicity is shown to be a balance between cancer adaptation and host immune recognition.
  • Adaptive evaders navigating diverse selective pressures result in heterogeneous post-escape tumor antigenicity, creating 'hot' and 'cold' tumors.

Conclusions:

  • Adaptive immune evasion is a key factor in cancer treatment failure.
  • Mathematical modeling provides insights into optimal cancer evasion strategies and their impact on tumor immunogenicity.
  • The study highlights the heterogeneity of tumor antigenicity following immune escape, influencing treatment response.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
593
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.0K